Home> Products> extended release feature

{ "products": [ { "_id": "666ae20ef7438b1754ba11bd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "QT-PINE SR 300 ", "description": "QT-PINE SR 300 \nQuetiapine Prolonged Release (300mg)\nIntroduction:\n\nQT-PINE SR 300 is a medication formulated with Quetiapine in a prolonged-release format, specifically designed to provide sustained therapeutic benefits for individuals dealing with various psychiatric disorders. Quetiapine, an atypical antipsychotic, is renowned for its effectiveness in managing schizophrenia, bipolar disorder, major depressive disorder (MDD), and related conditions.\nKey Features and Benefits:\n\nExtended Release Mechanism:\n\nQT-PINE SR 300 employs a prolonged-release mechanism to deliver Quetiapine gradually over an extended period. This feature ensures a consistent therapeutic concentration in the bloodstream, reducing the need for frequent dosing and enhancing treatment compliance.\nAntipsychotic and Mood Stabilizing Properties:\n\nQuetiapine, the active ingredient in QT-PINE SR 300, acts by blocking dopamine and serotonin receptors in the brain. This action helps alleviate psychotic symptoms like hallucinations and delusions in schizophrenia and stabilizes mood swings in bipolar disorder, preventing manic and depressive episodes.\nAntidepressant Effects:\n\nQT-PINE SR 300 is prescribed for major depressive disorder (MDD) due to Quetiapine's antidepressant properties. It modulates serotonin and norepinephrine levels, alleviating depressive symptoms and improving overall mood and well-being.\nAnxiolytic Action:\n\nThe anxiolytic (anxiety-reducing) effects of Quetiapine contribute to its efficacy in managing anxiety disorders such as generalized anxiety disorder (GAD) and social anxiety disorder (SAD).\nDosage and Administration:\n\nInitial Dosage and Adjustment:\nThe typical starting dose of QT-PINE SR 300 is 300mg taken orally once daily, preferably in the evening due to potential sedative effects. Dosage adjustments may be made by your healthcare provider based on individual response and tolerability.\nAdministration Instructions:\nSwallow the QT-PINE SR 300 tablet whole with water, without crushing or chewing it. Adhere strictly to the prescribed dosing schedule to maintain therapeutic blood levels.\nDuration of Treatment:\nContinue taking QT-PINE SR 300 as directed by your doctor, even if symptoms improve. Abrupt discontinuation can lead to relapse or withdrawal symptoms.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/qt-pine-sr-300-133621", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "GAD", "SAD", "need", "brain", "manic", "water", "300mg", "EMAIL", "doctor", "evening", "relapse", "Duration", "efficacy", "dopamine", "delusions", "medication", "qt-pine-sr", "well-being", "mood swings", "individuals", "information", "bloodstream", "sterispharma", "tolerability", "Introduction", "overall mood", "Key Features", "sterisonline", "effectiveness", "CALL/WHATSAPP", "schizophrenia", "hallucinations", "Initial Dosage", "extended period", "frequent dosing", "dosing schedule", "bipolar disorder", "active ingredient", "anxiety disorders", "Anxiolytic Action", "psychotic symptoms", "Dosage adjustments", "related conditions", "withdrawal symptoms", "serotonin receptors", "depressive episodes", "individual response", "healthcare provider", "depressive symptoms", "treatment compliance", "typical starting dose", "norepinephrine levels", "QT-PINE SR 300 tablet", "atypical antipsychotic", "Abrupt discontinuation", "Antidepressant Effects", "social anxiety disorder", "therapeutic blood levels", "prolonged-release format", "major depressive disorder", "antidepressant properties", "potential sedative effects", "Extended Release Mechanism", "Mood Stabilizing Properties", "Administration Instructions", "prolonged-release mechanism", "Quetiapine Prolonged Release", "generalized anxiety disorder", "various psychiatric disorders", "sustained therapeutic benefits", "consistent therapeutic concentration", "anxiolytic (anxiety-reducing) effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1884, "imageuri": "https://productimages.withfloats.com/actual/666ae213f068be46bdebab38.png", "tileimageuri": "https://productimages.withfloats.com/tile/666ae213f068be46bdebab38.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:11:58.983Z", "updatedon": "2024-06-26T07:38:28.861Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/qt-pine-sr-300-/1884", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "QT-PINE SR 300 ", "category": "NEUROLOGY RANGE", "tags": [ "qutipin 300 side effects", "quetiapine for sleep dosage", "qutipin is dangerous", "qutipin 25 uses", "quetiapine for sleep reviews" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ae115cee93a1bbc383b92", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "QT-PINE SR 200 ", "description": "QT-PINE SR 200 \nQuetiapine Prolonged Release (200mg)\nIntroduction:\n\nQT-PINE SR 200 is a medication containing Quetiapine in a prolonged-release formulation, designed to provide sustained therapeutic effects for individuals with psychiatric disorders. Quetiapine is an atypical antipsychotic known for its efficacy in managing schizophrenia, bipolar disorder, major depressive disorder (MDD), and other psychiatric conditions.\nKey Features and Benefits:\n\nExtended Release Formulation:\n\nQT-PINE SR 200 delivers Quetiapine in a prolonged-release manner, ensuring a steady concentration of the medication in the blood over an extended period. This feature reduces the frequency of dosing and enhances treatment adherence.\nAntipsychotic and Mood Stabilizing Actions:\n\nQuetiapine, the active ingredient in QT-PINE SR 200, acts by blocking dopamine and serotonin receptors in the brain, effectively reducing psychotic symptoms such as hallucinations and delusions in schizophrenia and bipolar disorder. It also helps stabilize mood swings in bipolar disorder, preventing manic and depressive episodes.\nAntidepressant Effects:\n\nQT-PINE SR 200 is prescribed for MDD, where it functions as an antidepressant by modulating serotonin and norepinephrine levels, alleviating depressive symptoms and improving overall well-being.\nAnxiolytic Properties:\n\nQuetiapine's anxiolytic properties contribute to its efficacy in managing anxiety disorders, including generalized anxiety disorder (GAD) and social anxiety disorder (SAD).\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of QT-PINE SR 200 is 200mg taken orally once daily, usually in the evening due to its sedative effects. Dosage adjustments may be made by your healthcare provider based on individual response and tolerability.\nAdministration: Swallow the QT-PINE SR 200 tablet whole with water, without crushing or chewing it. Follow the prescribed dosing schedule strictly to maintain therapeutic blood levels.\nDuration of Treatment: Continue taking QT-PINE SR 200 as directed by your doctor, even if symptoms improve. Abruptly stopping the medication can lead to relapse or withdrawal symptoms.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/qt-pine-sr-200-133620", "price": 124.0, "discountamount": 37.2, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "GAD", "SAD", "manic", "brain", "200mg", "EMAIL", "water", "doctor", "evening", "product", "relapse", "Duration", "efficacy", "Benefits", "dopamine", "frequency", "delusions", "medication", "qt-pine-sr", "mood swings", "information", "individuals", "sterispharma", "tolerability", "Key Features", "sterisonline", "Introduction", "CALL/WHATSAPP", "schizophrenia", "hallucinations", "Administration", "Initial Dosage", "release manner", "extended period", "bipolar disorder", "sedative effects", "anxiety disorders", "active ingredient", "overall well-being", "psychotic symptoms", "Dosage adjustments", "individual response", "depressive symptoms", "serotonin receptors", "depressive episodes", "healthcare provider", "treatment adherence", "withdrawal symptoms", "steady concentration", "QT-PINE SR 200 tablet", "Anxiolytic Properties", "norepinephrine levels", "psychiatric disorders", "typical starting dose", "atypical antipsychotic", "Antidepressant Effects", "social anxiety disorder", "therapeutic blood levels", "Mood Stabilizing Actions", "major depressive disorder", "prescribed dosing schedule", "Quetiapine Prolonged Release", "Extended Release Formulation", "generalized anxiety disorder", "other psychiatric conditions", "prolonged-release formulation", "sustained therapeutic effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1883, "imageuri": "https://productimages.withfloats.com/actual/666ae1184b514c761a318679.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ae1184b514c761a318679.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:07:49.791Z", "updatedon": "2024-06-26T07:39:42.48Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/qt-pine-sr-200-/1883", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "QT-PINE SR 200 ", "category": "NEUROLOGY RANGE", "tags": [ "qutipin 200 uses", "quetiapine for sleep reviews", "qutipin 200 mg side effects", "quetiapine reviews for depression" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666adf6d8999680f1480a619", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PROPENOL SR 40 ", "description": "PROPENOL SR 40 \nPropranolol SR (40mg)\nIntroduction:\n\nPROPENOL SR 40 is an extended-release formulation of Propranolol, a beta-blocker widely used for managing various cardiovascular conditions. This medication offers sustained therapeutic effects, reducing the frequency of dosing and providing continuous cardiovascular support.\n\nPROPENOL SR 40: Extended-Release Propranolol for Cardiovascular Health\n\nIntroduction:\n\nPROPENOL SR 40 is an extended-release formulation of Propranolol, a beta-blocker widely used for managing various cardiovascular conditions. This medication offers sustained therapeutic effects, reducing the frequency of dosing and providing continuous cardiovascular support.\n\nKey Features and Benefits:\n\nExtended-Release Formulation:\n\nPROPENOL SR 40 delivers Propranolol in a sustained manner, maintaining therapeutic levels in the bloodstream over an extended period.\nThis extended-release feature allows for once-daily dosing, improving patient compliance and convenience.\nCardiovascular Benefits:\n\nHypertension Management: Propranolol, a non-selective beta-blocker, effectively lowers blood pressure by blocking beta-adrenergic receptors, reducing heart rate and cardiac output.\nAngina Relief: It also helps manage angina pectoris by decreasing myocardial oxygen demand and improving exercise tolerance.\nAnxiety and Performance Management:\n\nPropranolol is beneficial in alleviating symptoms of anxiety, performance anxiety, and stage fright by blocking the effects of adrenaline, leading to a calmer physiological response.\nMigraine Prevention:\n\nPROPENOL SR 40 is also indicated for migraine prophylaxis, reducing the frequency and severity of migraine attacks by stabilizing blood vessels and modulating neurotransmitter release.\nDosage and Administration:\n\nRecommended Dosage: The typical starting dose of PROPENOL SR 40 for hypertension is 80mg once daily, which may be adjusted based on individual response.\nAdministration: Take PROPENOL SR 40 orally with water, preferably at the same time each day. Swallow the extended-release capsules whole without crushing or chewing.\nMonitoring: Regular monitoring of blood pressure and heart rate is essential during treatment to assess therapeutic response and adjust dosage if necessary.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/propenol-sr-40-134109", "price": 48.22, "discountamount": 33.75, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "80mg", "Order", "EMAIL", "water", "product", "severity", "symptoms", "same time", "frequency", "treatment", "heart rate", "medication", "adrenaline", "propenol-sr", "bloodstream", "PROPENOL SR", "information", "convenience", "Key Features", "sterispharma", "Introduction", "daily dosing", "sterisonline", "stage fright", "CALL/WHATSAPP", "blood vessels", "Angina Relief", "blood pressure", "Administration", "Propranolol SR", "cardiac output", "angina pectoris", "extended period", "sustained manner", "migraine attacks", "therapeutic levels", "patient compliance", "Recommended Dosage", "exercise tolerance", "Regular monitoring", "Migraine Prevention", "individual response", "performance anxiety", "therapeutic response", "migraine prophylaxis", "typical starting dose", "Cardiovascular Health", "selective beta-blocker", "Performance Management", "Hypertension Management", "Cardiovascular Benefits", "neurotransmitter release", "extended-release feature", "myocardial oxygen demand", "extended-release capsules", "beta-adrenergic receptors", "Extended-Release Propranolol", "extended-release formulation", "sustained therapeutic effects", "calmer physiological response", "continuous cardiovascular support", "various cardiovascular conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1881, "imageuri": "https://productimages.withfloats.com/actual/666adf70ae2cbfae74d23ceb.png", "tileimageuri": "https://productimages.withfloats.com/tile/666adf70ae2cbfae74d23ceb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:00:45.598Z", "updatedon": "2024-06-26T07:43:29.375Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/propenol-sr-40-/1881", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PROPENOL SR 40 ", "category": "NEUROLOGY RANGE", "tags": [ "PROPENOL SR 40", "Propranolol SR (40mg)", "PROPENOL SR 40 mg", "Provanol SR 40 side effects", "Provanol SR 40 uses", "Provanol SR 40 dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66694b54aebebd0900162c8e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ACOTIAMATE ER 300 ", "description": "Acotiamate ER 300 \nAcotiamide (300mg ER) is an extended-release formulation of acotiamide, a medication primarily used in the treatment of functional dyspepsia. Let's explore its key features:\n\nExtended-Release Formulation: Acotiamate ER 300 is designed to deliver the active ingredient, acotiamide, gradually over an extended period of time. This allows for sustained therapeutic effects, providing long-lasting relief from symptoms of functional dyspepsia.\n\nTherapeutic Use: Similar to its immediate-release counterpart, Acotiamate ER 300 is a gastroprokinetic agent used to alleviate symptoms associated with functional dyspepsia. It works by enhancing gastrointestinal motility and regulating the movement of food through the digestive tract, thereby reducing symptoms such as bloating, discomfort, early satiety, and postprandial fullness.\n\nMode of Action: Acotiamide, the active ingredient in Acotiamate ER 300, acts by inhibiting the breakdown of acetylcholine, a neurotransmitter involved in the regulation of gastrointestinal motility. By prolonging the action of acetylcholine, acotiamide helps to stimulate gastric emptying and improve the coordination of gastrointestinal muscle contractions, leading to relief of dyspeptic symptoms.\n\nClinical Efficacy: Clinical studies have demonstrated the effectiveness of Acotiamate ER 300 in reducing the severity and frequency of symptoms associated with functional dyspepsia. Its extended-release formulation allows for convenient once-daily dosing, leading to improved patient compliance and overall treatment outcomes.\n\nSafety Profile: Acotiamate ER 300 is generally well-tolerated, with most adverse effects being mild and transient. Common side effects may include headache, diarrhea, and nausea. Serious adverse reactions are rare but may include allergic reactions or severe gastrointestinal disturbances.\n\nDosage and Administration: Acotiamate ER 300 is typically available in extended-release tablet form, with each tablet containing 300mg of the active ingredient. The recommended dosage and administration schedule may vary depending on the individual's age, weight, and the severity of symptoms. It is usually taken orally, with or without food, as directed by a healthcare professional.\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \nCALL/WHATSAPP: 7877551268, 7849827488 \nBUY NOW", "price": 450.0, "discountamount": 135.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "BUY", "food", "time", "Mode", "EMAIL", "weight", "Dosage", "nausea", "bloating", "movement", "300mg ER", "diarrhea", "headache", "severity", "frequency", "breakdown", "medication", "Acotiamide", "regulation", "convenient", "discomfort", "individual", "information", "sterispharma", "daily dosing", "key features", "coordination", "CALL/WHATSAPP", "effectiveness", "acetylcholine", "early satiety", "ACOTIAMATE ER", "Safety Profile", "digestive tract", "extended period", "Therapeutic Use", "Clinical studies", "gastric emptying", "neurotransmitter", "Clinical Efficacy", "active ingredient", "patient compliance", "dyspeptic symptoms", "allergic reactions", "long-lasting relief", "Common side effects", "functional dyspepsia", "most adverse effects", "postprandial fullness", "gastroprokinetic agent", "healthcare professional", "administration schedule", "gastrointestinal motility", "Serious adverse reactions", "overall treatment outcomes", "extended-release formulation", "extended-release tablet form", "immediate-release counterpart", "sustained therapeutic effects", "severe gastrointestinal disturbances", "gastrointestinal muscle contractions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1771, "imageuri": "https://productimages.withfloats.com/actual/66694b62844f26002465fca8.png", "tileimageuri": "https://productimages.withfloats.com/tile/66694b62844f26002465fca8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T07:16:36.536Z", "updatedon": "2024-06-27T07:06:05.284Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/acotiamate-er-300-/1771", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ACOTIAMATE ER 300 ", "category": "Gastrology", "tags": [ "Acotiamate ER 300 गोली का उपयोग", "acotiamate er 300 गोली का उपयोग कैसे करते हैं", "Acotiamide (300mg ER)", "acotiamide side effects", "acotiamide before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66642af22bed1f08484d8342", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": " LANSOSTRUM 60", "description": "LANSOSTRUM 60\nDexlansoprazole (MR) (60mg)\nLansostrum 60 contains Dexlansoprazole (MR) in a strength of 60mg. Dexlansoprazole is a proton pump inhibitor (PPI) that works by reducing the amount of acid produced in the stomach. It is commonly prescribed to treat conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and stomach ulcers.\n\nDexlansoprazole (MR) differs from traditional dexlansoprazole formulations in that it is designed to provide extended-release action, maintaining acid suppression over a longer period compared to immediate-release formulations. This extended-release feature allows for once-daily dosing convenience.\n\nLansostrum 60, with Dexlansoprazole (MR) 60mg, helps relieve symptoms such as heartburn, regurgitation, and indigestion associated with GERD. It helps heal and prevent damage to the esophagus caused by stomach acid.\n\nIt's important to take Lansostrum 60 as directed by your healthcare provider. Common side effects may include headache, diarrhea, abdominal pain, and nausea. Serious side effects such as severe allergic reactions or Clostridium difficile-associated diarrhea (CDAD) are rare but should be reported to your doctor immediately if experienced.\n\nAs with any medication, discuss with your doctor about your medical history, other medications you are taking, and any allergies before starting Lansostrum 60 to ensure it is safe and appropriate for .\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/lansostrum-60-133773", "price": 210.0, "discountamount": 63.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "PPI", "60mg", "Call", "GERD", "CDAD", "ORDER", "Email", "doctor", "nausea", "damage", "amount", "headache", "strength", "WhatsApp", "symptoms", "allergies", "heartburn", "esophagus", "conditions", "LANSOSTRUM", "information", "indigestion", "sterispharma", "sterisonline", "stomach acid", "regurgitation", "longer period", "stomach ulcers", "abdominal pain", "medical history", "acid suppression", "other medications", "healthcare provider", "Common side effects", "Dexlansoprazole (MR", "erosive esophagitis", "Serious side effects", "proton pump inhibitor", "extended-release action", "extended-release feature", "daily dosing convenience", "severe allergic reactions", "immediate-release formulations", "gastroesophageal reflux disease", "traditional dexlansoprazole formulations", "Clostridium difficile-associated diarrhea" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1569, "imageuri": "https://productimages.withfloats.com/actual/66642af51a59977b77dffe1c.png", "tileimageuri": "https://productimages.withfloats.com/tile/66642af51a59977b77dffe1c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T09:57:06.613Z", "updatedon": "2024-06-28T09:31:27.591Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/-lansostrum-60/1569", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": " LANSOSTRUM 60", "category": "GASTROLOGYRANGE", "tags": [ "LANSOSTRUM 60", "Dexlansoprazole (MR) (60mg)", "Dexlansoprazole side effects", "Dexlansoprazole 60 mg uses", "Dexlansoprazole 60 mg price", "Dexlansoprazole vs omeprazole" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6639c4d7edbab11d945aa483", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EPSTATE SR 150", "description": "EPSTATE SR 150\nEpalrestat Tablets ER (50mg)\nEPSTATE SR 150 features Epalrestat Tablets ER, an extended-release formulation specifically designed to manage and treat diabetic neuropathy. Each tablet contains 150 mg of Epalrestat, which effectively inhibits aldose reductase. This action is crucial in slowing the glucose conversion into sorbitol, a sugar alcohol that, when accumulated, contributes to nerve, eye, and kidney damage associated with diabetes. By managing this pathway, EPSTATE SR 150 helps alleviate symptoms such as pain, numbness, and tingling sensations in the limbs, thus enhancing the quality of life for diabetic patients. This medication is a step forward in preventive diabetic care, focusing on long-term nerve health.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n", "price": 189.0, "discountamount": 57.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "eye", "step", "life", "pain", "limbs", "150 mg", "action", "pathway", "quality", "sorbitol", "diabetes", "numbness", "symptoms", "EPSTATE SR", "medication", "sensations", "sugar alcohol", "kidney damage", "aldose reductase", "diabetic patients", "glucose conversion", "diabetic neuropathy", "Epalrestat Tablets ER", "long-term nerve health", "preventive diabetic care", "extended-release formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1145, "imageuri": "https://productimages.withfloats.com/actual/6639c4f80070ce584f5b3dc4.png", "tileimageuri": "https://productimages.withfloats.com/tile/6639c4f80070ce584f5b3dc4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-07T06:06:15.321Z", "updatedon": "2024-06-11T12:03:33.198Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/epstate-sr-150/1145", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Epalrestat Tablets ER (50mg)", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-09-25T10:46:50.098Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b0256b813270ffac595cb0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 100", "description": "TRELAQWK 100 is an advanced oral antidiabetic medication containing Trelagliptin 100 mg, specifically designed for adults with type 2 diabetes mellitus (T2DM). Belonging to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors, this formulation helps improve blood glucose control when used along with a proper diet and regular exercise.\nWith its once-weekly dosage regimen, TRELAQWK 100 offers a convenient treatment option, enhancing patient compliance and simplifying long-term diabetes management.\nKey Ingredient\nTrelagliptin 100 mg\nA long-acting DPP-4 inhibitor that regulates blood glucose levels by enhancing incretin hormones. These incretins stimulate insulin secretion and suppress glucagon release, helping to achieve better glycemic control.\nKey Benefits of TRELAQWK 100\nWeekly dosing ensures greater convenience and adherence\nReduces both fasting and postprandial blood sugar levels\nSupports natural blood sugar regulation without weight gain\nLow risk of hypoglycemia, especially when used as monotherapy or with non-insulin therapies\nCan be prescribed as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas\nHow TRELAQWK 100 Works\nTRELAQWK 100 functions by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).\nThese incretin hormones:\nStimulate insulin secretion in response to meals\nReduce glucagon release, lowering blood sugar levels\nThanks to its extended half-life, trelagliptin allows for once-weekly dosing, unlike other DPP-4 inhibitors that require daily administration.\nDirections for Use\nDosage: Take one tablet of TRELAQWK 100 once weekly, or as directed by your physician\nAdministration: May be taken with or without food, ideally on the same day each week\nMissed dose: Do not double the dose; consult your healthcare provider for guidance\nPossible Side Effects\nTRELAQWK 100 is usually well-tolerated, but some individuals may experience:\nMild headache\nNasopharyngitis (common cold-like symptoms)\nConstipation\nUpper respiratory tract infections\nRare skin allergies (rash, itching)\n👉 If you experience persistent abdominal pain, severe rashes, or symptoms suggestive of pancreatitis, stop the medication and seek medical care immediately.", "price": 550.0, "discountamount": 165.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2166, "imageuri": "https://productimages.withfloats.com/actual/68b0256ebb42c3d551ad314c.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b0256ebb42c3d551ad314c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:46:19.602Z", "updatedon": "2025-08-28T09:46:19.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-100/2166", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "trelagliptin 100 mg", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6842b8014256f7114dfbd884", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 100", "description": "Trelagliptin 100mg in TRELAQWK 100 is an innovative once-weekly oral medication formulated with Trelagliptin 100mg, specifically designed to support adults in managing type 2 diabetes mellitus (T2DM). As a member of the Dipeptidyl Peptidase-4 (DPP-4) inhibitor class, it provides a simplified and effective approach to improving glycemic control when combined with a healthy diet and regular exercise. Its weekly dosing schedule enhances treatment adherence, offering a more sustainable option for long-term diabetes care.\n\nActive Ingredient:\nTrelagliptin 100mg\nA potent, long-acting DPP-4 inhibitor that helps maintain stable blood glucose levels by preserving incretin activity. Incretins are natural hormones that promote insulin release and suppress glucagon, playing a vital role in blood sugar regulation.\n\nCore Benefits:\nConvenient once-weekly dosing enhances patient compliance\n\nEffectively lowers both fasting and postprandial (after-meal) blood sugar\n\nPromotes natural insulin production without contributing to weight gain\n\nCarries a low risk of hypoglycemia, especially when not used with insulin\n\nCan be used alone or in combination with other antidiabetic medications like metformin or sulfonylureas\n\nMechanism of Action:\nTRELAQWK 100 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These hormones play a crucial role in regulating blood sugar after meals. By prolonging their activity, Trelagliptin enhances insulin secretion and reduces glucagon levels, resulting in improved glycemic control. Its extended half-life allows for once-a-week administration, setting it apart from daily DPP-4 inhibitors.\n\nDosage & Administration:\nRecommended Dose: One tablet per week, or as advised by your doctor\n\nHow to Take: With or without food, preferably on the same day each week\n\nIf a dose is missed, do not double the next dose; seek guidance from your healthcare provider\n\nPossible Side Effects:\nTRELAQWK 100 is generally safe and well-tolerated. Some individuals may experience:\n\nHeadache\n\nNasopharyngitis (mild cold symptoms)\n\nConstipation\n\nUpper respiratory tract infections\n\nRare allergic reactions such as rashes or skin irritation\n\nSeek immediate medical advice if you experience unusual symptoms such as severe abdominal pain, persistent skin reactions, or signs of pancreatitis.", "price": 3.0, "discountamount": 1.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "medical advice", "generally safe", "healthcare provider", "food preferably", "extended halflife", "crucial role", "dpp4 enzyme", "sulfonylureas mechanism", "antidiabetic medications", "low risk", "vital role", "sustainable option", "regular exercise", "healthy diet", "effective approach", "support adults", "trelaqwk 100trelaqwk 100", "hormones play", "natural hormones", "dose seek guidance", "promote insulin release", "degrades incretin hormones", "experience unusual symptoms", "skin irritation seek", "onceaweek administration setting", "improved glycemic control", "regulating blood sugar", "weight gain carries", "suppress glucagon playing", "improving glycemic control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2132, "imageuri": "https://productimages.withfloats.com/actual/6842b80c8a53ae8db15a02ac.png", "tileimageuri": "https://productimages.withfloats.com/tile/6842b80c8a53ae8db15a02ac.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-06T09:42:25.371Z", "updatedon": "2025-06-11T11:17:09.096Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-100/2132", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Trelagliptin 100mg", "category": "DIABETIC RANGE", "tags": [ "Trelagliptin side effects", "Trelagliptin brand name", "Trelagliptin brands in India", "Trelagliptin uses", "Trelagliptin 100mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }